Lemonade, Inc. (LMND)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
Research Workspace
Put LMND beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Property & Casualty Insurance is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Positive cash flow from operations sustained: OCF -0.6M vs >0M target.
View ThesisRevenue growth is accelerating — up about 62% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 19%, softest on free-cash-flow margins.
View QualityManagement screens weak on capital allocation, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 51% in its worst 12-month stretch.
View RiskLMND's growth relies on its ability to increase revenue and In Force Premium growth. Revenue grew 79% year over year, and the last quarter met expectations. LMND trades at 8.2× P/B versus a peer median of 1.7×, indicating the price reflects less growth than forecasted. The primary risk is the company's negative cash flow from operations, which fell short of targets. Peer multiples imply a price about 54% below where it trades. Our read is provisional.
Trailing returns as of 2026-09-04. LMND is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering LMND (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for LMND in the last 4 months.
Continue this research
Compare LMND with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| LMND Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Property & Casualty Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put LMND next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase revenue and In Force Premium growth
New product launch supports revenue and premium growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $53.41
The last 12 months of price, then the range of analyst 12-month targets from today’s $53.41.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.

Advances: Increase revenue guidance for FY 2026
Expansion into new markets supports revenue growth.
Advances: Improve Adjusted EBITDA loss
Testing new insurance models may improve profitability.